162 research outputs found
Automated psychological therapy using immersive virtual reality for treatment of fear of heights: A single-blind, parallel-group, randomised controlled trial
Background
Engaging, interactive, and automated virtual reality (VR) treatments might help solve the unmet needs of individuals with mental health disorders. We tested the efficacy of an automated cognitive intervention for fear of heights guided by an avatar virtual coach (animated using motion and voice capture of an actor) in VR and delivered with the latest consumer equipment.
Methods
We did a randomised trial of automated VR versus usual care. We recruited adults aged older than 18 years with a fear of heights by radio advertisements in Oxfordshire, UK. We diagnosed fear of heights if participants scored more than 29 on the Heights Interpretation Questionnaire (HIQ). We randomly allocated participants by computer in a 1:1 ratio to either automated VR delivered in roughly six 30-min sessions administered about two to three times a week over a 2-week period (intervention group) or to usual care (control group). Randomisation was stratified by severity of fear of heights. The research team, who were unaware of the random allocation, administered three fear-of-height assessments, at baseline (0 weeks), at the end of treatment (2 weeks), and at follow-up (4 weeks). The primary outcome measure was HIQ score (range 16β80, with higher scores indicating greater severity). This trial is registered with the ISRCTN registry, number ISRCTN11898283.
Findings
Between Nov 25, 2017, and Feb 27, 2018, 100 individuals were enrolled and underwent randomisation, of whom 49 were assigned to the VR treatment group and 51 to the control group. All participants completed the 4-week follow-up. The mean total treatment time in VR was 124Β·43 min (SD 34Β·23). Compared with participants in the control group, the VR treatment reduced fear of heights at the end of treatment (mean change score β24Β·5 [SD 13Β·1] in the VR group vs β1Β·2 [7Β·3] in the control group; adjusted difference β24Β·0, 95% CI β27Β·7 to β20Β·3; Cohen's d=2Β·0; p<0Β·0001). The benefit was maintained at follow-up (mean change score β25Β·1 [SD 13Β·9] in the VR group vs β1Β·5 [7Β·8] in the control group; adjusted difference β24Β·3, 95% CI β27Β·9 to β20Β·6; Cohen's d=2Β·0; p<0Β·0001). The number needed to treat to at least halve the fear of heights was 1Β·3. No adverse events were reported.
Interpretation
Psychological therapy delivered automatically by a VR coach can produce large clinical benefits. Evidence-based VR treatments have the potential to greatly increase treatment provision for mental health disorders
Interventions addressing challenging behaviours in Arab children and adults with intellectual disabilities and/or autism : a systematic review
Background: Arabs with intellectual disabilities and/or autism may exhibit challenging behaviour that affects them and their caregivers. Early, appropriate intervention may reduce these effects. This review synthesised and critically appraised challenging behaviour intervention research for this population.
Methods: All published empirical research on challenging behaviour interventions for Arabs with intellectual disabilities and/or autism was included. In September 2022, 15 English and Arabic databases yielded 5,282 search records. Studies were appraised using the MMAT. Review findings were narratively synthesised.
Results: The 79 included studies (n= 1,243 participants) varied in design, intervention, and evaluation method. Only 12.6% of interventions were well-designed and reported. Arab interventions primarily targeted children, were applied collectively on small samples, lacked individualised assessment, and were based on an inconsistent understanding of challenging behaviour.
Conclusion: The evidence base on interventions for Arabs with intellectual disabilities and/or autism and challenging behaviour needs strengthening. Attention should be given to culturally relevant adaptations
Automated psychological therapy using immersive virtual reality for treatment of fear of heights:a single-blind, parallel-group, randomised controlled trial
Background: Engaging, interactive, and automated virtual reality (VR) treatments might help solve the unmet needs of individuals with mental health disorders. We tested the efficacy of an automated cognitive intervention for fear of heights guided by an avatar virtual coach (animated using motion and voice capture of an actor) in VR and delivered with the latest consumer equipment. Methods: We did a randomised trial of automated VR versus usual care. We recruited adults aged older than 18 years with a fear of heights by radio advertisements in Oxfordshire, UK. We diagnosed fear of heights if participants scored more than 29 on the Heights Interpretation Questionnaire (HIQ). We randomly allocated participants by computer in a 1:1 ratio to either automated VR delivered in roughly six 30-min sessions administered about two to three times a week over a 2-week period (intervention group) or to usual care (control group). Randomisation was stratified by severity of fear of heights. The research team, who were unaware of the random allocation, administered three fear-of-height assessments, at baseline (0 weeks), at the end of treatment (2 weeks), and at follow-up (4 weeks). The primary outcome measure was HIQ score (range 16β80, with higher scores indicating greater severity). This trial is registered with the ISRCTN registry, number ISRCTN11898283. Findings: Between Nov 25, 2017, and Feb 27, 2018, 100 individuals were enrolled and underwent randomisation, of whom 49 were assigned to the VR treatment group and 51 to the control group. All participants completed the 4-week follow-up. The mean total treatment time in VR was 124Β·43 min (SD 34Β·23). Compared with participants in the control group, the VR treatment reduced fear of heights at the end of treatment (mean change score β24Β·5 [SD 13Β·1] in the VR group vs β1Β·2 [7Β·3] in the control group; adjusted difference β24Β·0, 95% CI β27Β·7 to β20Β·3; Cohen's d=2Β·0; p<0Β·0001). The benefit was maintained at follow-up (mean change score β25Β·1 [SD 13Β·9] in the VR group vs β1Β·5 [7Β·8] in the control group; adjusted difference β24Β·3, 95% CI β27Β·9 to β20Β·6; Cohen's d=2Β·0; p<0Β·0001). The number needed to treat to at least halve the fear of heights was 1Β·3. No adverse events were reported. Interpretation: Psychological therapy delivered automatically by a VR coach can produce large clinical benefits. Evidence-based VR treatments have the potential to greatly increase treatment provision for mental health disorders.</p
A new method to analyse the pace of child development: Cox regression validated by a bootstrap resampling procedure
<p>Abstract</p> <p>Background</p> <p>Various perinatal factors influencing neuromotor development are known from cross sectional studies. Factors influencing the age at which distinct abilities are acquired are uncertain. We hypothesized that the Cox regression model might identify these factors.</p> <p>Methods</p> <p>Neonates treated at Aachen University Hospital in 2000/2001 were identified retrospectively (n = 796). Outcome data, based on a structured interview, were available from 466 children, as were perinatal data. Factors possibly related to outcome were identified by bootstrap selection and then included into a multivariate Cox regression model. To evaluate if the parental assessment might change with the time elapsed since birth we studied five age cohorts of 163 normally developed children.</p> <p>Results</p> <p>Birth weight, gestational age, congenital cardiac disease and periventricular leukomalacia were related to outcome in the multivariate analysis (p < 0.05). Analysis of the control cohorts revealed that the parents' assessment of the ability of bladder control is modified by the time elapsed since birth.</p> <p>Conclusions</p> <p>Combined application of the bootstrap resampling procedure and multivariate Cox regression analysis effectively identifies perinatal factors influencing the age at which distinct abilities are acquired. These were similar as known from previous cross sectional studies. Retrospective data acquistion may lead to a bias because the parental memories change with time. This recommends applying this statistical approach in larger prospective trials.</p
The Energy Density in the Maxwell-Chern-Simons Theory
A two-dimensional nonrelativistic fermion system coupled to both
electromagnetic gauge fields and Chern-Simons gauge fields is analysed.
Polarization tensors relevant in the quantum Hall effect and anyon
superconductivity are obtained as simple closed integrals and are evaluated
numerically for all momenta and frequencies. The correction to the energy
density is evaluated in the random phase approximation (RPA), by summing an
infinite series of ring diagrams. It is found that the correction has
significant dependence on the particle number density.
In the context of anyon superconductivity, the energy density relative to the
mean field value is minimized at a hole concentration per lattice plaquette
(0.05 \sim 0.06) (p_c a/\hbar)^2 where p_c and a are the momentum cutoff and
lattice constant, respectively. At the minimum the correction is about -5 %
\sim -25 %, depending on the ratio (2m \omega_c)/(p_c^2) where \omega_c is the
frequency cutoff.
In the Jain-Fradkin-Lopez picture of the fractional quantum Hall effect the
RPA correction to the energy density is very large. It diverges logarithmically
as the cutoff is removed, implying that corrections beyond RPA become important
at large momentum and frequency.Comment: 19 pages (plain Tex), 12 figures not included, UMN-TH-1246/9
Recommended from our members
When do apples stop growing, and why does it matter?
Apples in the commercial food chain are harvested up to two weeks before maturity. We explore apple fruit development through the growing season to establish the point at which physical features differentiating those cultivars become evident. This is relevant both for the understanding of the growing process and to ensure that any identification and classification tools can be used both on ripened-on-tree and stored fruit. Current literature presents some contradictory findings on apple growth, we studied 12 apple cultivars in the Brogdale National Fruit Collection, UK over two seasons to establish patterns of growth. Fruit were sampled at regular time points throughout the growing season and four morphometrics (maximum length, maximum diameter, weight, and centroid size) were collected. These were regressed against growing degree days in order to appropriately describe the growth pattern observed. All four morphometrics were adequately described using log-log linear regressions, with adjusted R2 estimates ranging from 78.3% (maximum length) to 86.7% (weight). For all four morphometrics, a 10% increase in growing degree days was associated with a 1% increase in the morphometric. Our findings refine previous work presenting rapid early growth followed by a plateau in later stages of development and contrast with published expo-linear models. We established that apples harvested for commercial storage purposes, two weeks prior to maturity, showed only a modest decrease in size compared with ripened-on-tree fruit, demonstrating that size morphometric approaches are appropriate for classification of apple fruit at point of harvest
Avaliação sorológica da vacina oral, tipo Sabin, contra a poliomielite em região semi - rural: II - Aspectos quantitativos dos anticorpos formados e anticorpos para outros enterovirus
Defending the genome from the enemy within:mechanisms of retrotransposon suppression in the mouse germline
The viability of any species requires that the genome is kept stable as it is transmitted from generation to generation by the germ cells. One of the challenges to transgenerational genome stability is the potential mutagenic activity of transposable genetic elements, particularly retrotransposons. There are many different types of retrotransposon in mammalian genomes, and these target different points in germline development to amplify and integrate into new genomic locations. Germ cells, and their pluripotent developmental precursors, have evolved a variety of genome defence mechanisms that suppress retrotransposon activity and maintain genome stability across the generations. Here, we review recent advances in understanding how retrotransposon activity is suppressed in the mammalian germline, how genes involved in germline genome defence mechanisms are regulated, and the consequences of mutating these genome defence genes for the developing germline
- β¦